A Phase 2, Randomized, Controlled Trial of Best Systemic Therapy Versus Best Systemic Therapy with Definitive Treatment of the Primary Tumor in Metastatic Prostate Cancer

European Urology 2026

View at publisher
Authors: Brian F. Chapin, Marc Smaldone, Amado J. Zurita, Jennifer Wang, Matthew R. Cooperberg, Martin Gleave, Scott E. Delacroix, John P Davis, Curtis Pettaway, Louis Pisters, Mehrad Adibi, Lisly Chery
+26 more John Papadopoulos, John Ward, Justin Gregg, Neema Navai, Paul Corn, Sumit K. Subudhi, Christopher Logothetis, Deborah Kuban, Quynh Anh Nguyen, Chad Tang, Seungtaek Choi, Karen Hoffman, Marisa Lozano, Mohamed Elsheftawi, Mary Achim, Yuehui Zhao, Naveen Ramesh, Emi Sei, Nicholas E. Navin, Graciela M. Nogueras Gonzalez, Xuemei Wang, Keyi Zhu, Patricia Troncoso, Miao Zhang, Sean McGuire, Ana Aparicio
DOI: 10.1016/j.eururo.2026.02.011
Cited by: 2
References: 26

Fields of Study & Subjects

Prostate Cancer Treatment and Research Prostate Cancer Diagnosis and Treatment Clusterin in disease pathology

Publication details

Journal / source
European Urology
Publisher
Elsevier BV
Volume
90
Issue
2
Pages
125–136
Publication date
14 March 2026
Language
EN